Wellington Shields & Co’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Sell
4,929
-130
-3% -$44.5K 0.4% 54
2026
Q1
$1.78M Sell
5,059
-250
-5% -$89.1K 0.45% 53
2025
Q4
$1.74M Buy
5,309
+250
+5% +$79.3K 0.43% 54
2025
Q3
$1.43M Hold
5,059
0.37% 66
2025
Q2
$1.41M Sell
5,059
-100
-2% -$28.3K 0.4% 65
2025
Q1
$1.61M Buy
5,159
+345
+7% +$102K 0.5% 46
2024
Q4
$1.25M Hold
4,814
0.38% 58
2024
Q3
$1.55M Sell
4,814
-200
-4% -$65.4K 0.47% 52
2024
Q2
$1.57M Sell
5,014
-400
-7% -$118K 0.51% 44
2024
Q1
$1.54M Buy
5,414
+600
+12% +$176K 0.52% 40
2023
Q4
$1.39M Hold
4,814
0.51% 44
2023
Q3
$1.29M Buy
4,814
+1,400
+41% +$349K 0.32% 48
2023
Q2
$758K Sell
3,414
-1,400
-29% -$325K 0.18% 84
2023
Q1
$1.16M Buy
4,814
+200
+4% +$49.1K 0.26% 53
2022
Q4
$1.21M Hold
4,614
0.28% 49
2022
Q3
$1.04M Buy
4,614
+3
+0.1% +$727 0.45% 53
2022
Q2
$1.12M Buy
4,611
+3
+0.1% +$735 0.27% 53
2022
Q1
$1.11M Buy
4,608
+3
+0.1% +$689 0.37% 70
2021
Q4
$1.04M Buy
4,605
+769
+20% +$162K 0.21% 75
2021
Q3
$816K Buy
3,836
+2
+0.1% +$460 0.28% 82
2021
Q2
$934K Sell
3,834
-147
-4% -$36.2K 0.31% 79
2021
Q1
$991K Sell
3,981
-398
-9% -$95K 0.36% 73
2020
Q4
$1.01M Buy
4,379
+136
+3% +$31.4K 0.36% 65
2020
Q3
$1.08M Buy
4,243
+3
+0.1% +$743 0.45% 54
2020
Q2
$1M Sell
4,240
-132
-3% -$30.1K 0.44% 53
2020
Q1
$886K Buy
4,372
+2
+0% +$437 0.49% 56
2019
Q4
$1.05M Buy
+4,370
New +$963K 0.47% 63
2019
Q3
Sell
-4,215
Closed -$777K 96
2019
Q2
$777K Buy
4,215
+2
+0% +$358 0.37% 79
2019
Q1
$800K Buy
4,213
+3
+0.1% +$573 0.41% 71
2018
Q4
$820K Buy
+4,210
New +$821K 0.47% 62
2016
Q1
Sell
-1,264
Closed -$205K 110
2015
Q4
$205K Buy
+1,264
New +$199K 0.14% 98
2015
Q2
Sell
-1,254
Closed -$200K 109
2015
Q1
$200K Buy
+1,254
New +$197K 0.12% 101
2014
Q2
Sell
-1,693
Closed -$209K 114
2014
Q1
$209K Buy
+1,693
New +$205K 0.13% 98

Other funds holding AMGN

Wellington Shields & Co's AMGN Position: Q2 2026 in Review

Wellington Shields & Co reduced its Amgen (AMGN) stake by 2.6% in Q2 2026, selling an estimated $44.5K and leaving 4,929 shares worth $1.78M. The position accounts for 0.4% of the portfolio, ranked #54.

Wellington Shields & Co first reported a position in AMGN in Q1 2014 and has held it in 33 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wellington Shields & Co held 4,929 shares of Amgen worth $1.78M as of Q2 2026.
  • Wellington Shields & Co sold 130 Amgen shares in Q2 2026, an estimated $44.5K.
  • Amgen made up 0.4% of Wellington Shields & Co's portfolio in Q2 2026, its #54 holding.
  • Wellington Shields & Co first reported a position in Amgen in Q1 2014 and has held it in 33 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.